{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:55:13Z","timestamp":1793163313268,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T00:00:00Z","timestamp":1503360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","jaad.org","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.jaad.2017.08.029","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T00:46:53Z","timestamp":1507769213000},"page":"90-99.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Adalimumab for nail psoriasis: Efficacy and safety from the first 26\u00a0weeks of a phase 3, randomized, placebo-controlled trial"],"prefix":"10.1016","volume":"78","author":[{"given":"Boni E.","family":"Elewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin M.","family":"Okun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Papp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J.","family":"Crowley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"Guillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murali","family":"Sundaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Poulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihua","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqian","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phoebe A.","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2017.08.029_bib1","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000246274","article-title":"Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,728 patients","volume":"193","author":"de Jong","year":"1996","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2017.08.029_bib2","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1365-2133.2010.09831.x","article-title":"Nail psoriasis in Germany: epidemiology and burden of disease","volume":"163","author":"Augustin","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.08.029_bib3","first-page":"1","article-title":"Nail psoriasis as a severity indicator: results from the PsoReal study","volume":"2","author":"Radtke","year":"2011","journal-title":"Patient Relat Outcome Meas"},{"key":"10.1016\/j.jaad.2017.08.029_bib4","series-title":"Nail Psoriasis: A to Z","first-page":"1","article-title":"Epidemiology of nail psoriasis","author":"Richert","year":"2014"},{"key":"10.1016\/j.jaad.2017.08.029_bib5","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1016\/j.jaad.2010.10.021","article-title":"A significant association exists between the severity of nail and skin involvement in psoriasis","volume":"66","author":"Hallaji","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.08.029_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2005.07.073","article-title":"Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy","volume":"57","author":"Jiaravuthisan","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.08.029_bib7","first-page":"203","article-title":"Nail psoriasis\u2014a treatment challenge","volume":"11","author":"Radtke","year":"2013","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2017.08.029_bib8","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/rheumatology\/keh198","article-title":"Extended report: nail disease in psoriatic arthritis\u2014clinically important, potentially treatable and often overlooked","volume":"43","author":"Williamson","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaad.2017.08.029_bib9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1468-3083.2011.04349.x","article-title":"Recommendations for the treatment of nail psoriasis in patients with moderate to severe psoriasis: a dermatology expert group consensus","volume":"26","author":"Langley","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.08.029_bib10","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000232309","article-title":"Management of difficult to treat locations of psoriasis. Scalp, face, flexures, palm\/soles and nails","volume":"38","author":"Kragballe","year":"2009","journal-title":"Curr Probl Dermatol"},{"key":"10.1016\/j.jaad.2017.08.029_bib11","first-page":"CD007633","article-title":"Interventions for nail psoriasis","author":"de Vries","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"suppl 1","key":"10.1016\/j.jaad.2017.08.029_bib12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000316179","article-title":"Treatment and management of psoriasis with nail involvement: a focus on biologic therapy","volume":"221","author":"Langley","year":"2010","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2017.08.029_bib13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1001\/jamadermatol.2014.2983","article-title":"Treatment of nail psoriasis: best practice recommendations from the Medical Board of the National Psoriasis Foundation","volume":"151","author":"Crowley","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2017.08.029_bib14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/archdermatol.2010.384","article-title":"Adalimumab for treatment of moderate to severe chronic plaque psoriasis of the hands and feet: efficacy and safety results from REACH, a randomized, placebo-controlled, double-blind trial","volume":"147","author":"Leonardi","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.08.029_bib15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/jdv.12553","article-title":"Adalimumab for the treatment of moderate to severe psoriasis: subanalysis of effects on scalp and nails in the BELIEVE study","volume":"29","author":"Thaci","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.08.029_bib16","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/ard.2009.111856","article-title":"Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions","volume":"69","author":"Van den Bosch","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2017.08.029_bib17","doi-asserted-by":"crossref","first-page":"A127","DOI":"10.1016\/j.jval.2016.03.519","article-title":"Evaluation of a novel clinician reported outcome in nail psoriasis [abstract]","volume":"19","author":"Hudgens","year":"2016","journal-title":"Value Health"},{"key":"10.1016\/j.jaad.2017.08.029_bib18","first-page":"123","article-title":"The modified Nail Psoriasis\u00a0Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis","volume":"34","author":"Cassell","year":"2007","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jaad.2017.08.029_bib19","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1067\/S0190-9622(03)00910-1","article-title":"Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis","volume":"49","author":"Rich","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.08.029_bib20","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3899\/jrheum.140177","article-title":"The Brigham Scalp Nail Inverse Palmoplantar Psoriasis Composite Index (B-SNIPI): a\u00a0novel index to measure all non-plaque psoriasis subsets","volume":"41","author":"Patel","year":"2014","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jaad.2017.08.029_bib21","unstructured":"World Health Organization. Body mass index (BMI) classifications. Available at: www.who.int\/nutrition\/publications\/obesity\/WHO_TRS_894\/en\/. Accessed September 26, 2016."},{"key":"10.1016\/j.jaad.2017.08.029_bib22","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/1203475416655705","article-title":"2016 Addendum to the Canadian Guidelines for the Management of Plaque Psoriasis 2009","volume":"20","year":"2016","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2017.08.029_bib23","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/09546630701646172","article-title":"Impact of adalimumab treatment on patient-reported outcomes: results from a phase III clinical trial in patients with moderate to severe plaque psoriasis","volume":"18","author":"Revicki","year":"2007","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2017.08.029_bib24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40257-016-0222-4","article-title":"Managing scalp psoriasis: an evidence-based review","volume":"18","author":"Wang","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2017.08.029_bib25","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.3899\/jrheum.140881","article-title":"Treatments for nail psoriasis: a systematic review by the GRAPPA Nail Psoriasis Work Group","volume":"41","author":"Armstrong","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2017.08.029_bib26","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000317775","article-title":"Skin and nail responses after 1 year of infliximab therapy in patients with moderate-to-severe psoriasis: a retrospective analysis of the EXPRESS Trial","volume":"221","author":"Reich","year":"2010","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2017.08.029_bib27","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/bjd.12060","article-title":"A 24-week randomized clinical trial investigating the efficacy and safety of two doses of etanercept in nail psoriasis","volume":"168","author":"Ortonne","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.08.029_bib28","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/bjd.12632","article-title":"Ustekinumab improves nail disease in patients with moderate-to-severe psoriasis: results from PHOENIX 1","volume":"170","author":"Rich","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.08.029_bib29","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1056\/NEJMoa1109997","article-title":"Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis","volume":"366","author":"Leonardi","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2017.08.029_bib30","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1111\/jdv.12359","article-title":"Secukinumab improves hand, foot and nail lesions in moderate-to-severe plaque psoriasis: subanalysis of a randomized, double-blind, placebo-controlled, regimen-finding phase 2 trial","volume":"28","author":"Paul","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.08.029_bib31","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/j.1468-3083.2010.03927.x","article-title":"Evaluation of the efficacy of methotrexate and cyclosporine therapies on psoriatic nails: a one-blind, randomized study","volume":"25","author":"Gumusel","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.08.029_bib32","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/bjd.13272","article-title":"Nail involvement as a predictor of concomitant psoriatic arthritis in patients with psoriasis","volume":"171","author":"Langenbruch","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.08.029_bib33","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1111\/j.1468-3083.2009.03372.x","article-title":"Scalp psoriasis: European consensus on grading and treatment algorithm","volume":"23","author":"Ortonne","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.08.029_bib34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/00128071-200102030-00005","article-title":"Psoriasis of the scalp. Diagnosis and management","volume":"2","author":"van de Kerkhof","year":"2001","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2017.08.029_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00403-010-1080-1","article-title":"Definition of treatment goals for moderate to severe psoriasis: a European consensus","volume":"303","author":"Mrowietz","year":"2011","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2017.08.029_bib36","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.clindermatol.2007.10.026","article-title":"Psoriasis treatment in difficult locations: scalp,\u00a0nails,\u00a0and intertriginous areas","volume":"26","author":"Wozel","year":"2008","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2017.08.029_bib37","first-page":"70","article-title":"Scalp psoriasis","volume":"9","author":"Wozel","year":"2011","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2017.08.029_bib38","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1365-2133.2010.09791.x","article-title":"A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol\/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE study","volume":"163","author":"Thaci","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.08.029_bib39","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1365-2133.2007.08315.x","article-title":"Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION)","volume":"158","author":"Saurat","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.08.029_bib40","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jaad.2007.09.010","article-title":"Adalimumab therapy for moderate to severe psoriasis: a randomized, controlled phase III trial","volume":"58","author":"Menter","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.08.029_bib41","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/annrheumdis-2011-201244","article-title":"Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease","volume":"72","author":"Burmester","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2017.08.029_bib42","unstructured":"AbbVie Ltd. Humira (adalimumab) Summary of product characteristics. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000481\/WC500050870.pdf. Accessed April 14, 2017."},{"key":"10.1016\/j.jaad.2017.08.029_bib43","unstructured":"Humira (adalimumab) [package insert]. North Chicago, IL: AbbVie Inc. Available at: http:\/\/www.rxabbvie.com\/pdf\/humira.pdf. Accessed April 14, 2017."}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962217322624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962217322624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T15:58:04Z","timestamp":1723651084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962217322624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0190962217322624"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2017.08.029","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adalimumab for nail psoriasis: Efficacy and safety from the first 26\u00a0weeks of a phase 3, randomized, placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2017.08.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}